Research Context

GHK-Cu has been widely studied in vitro and in vivo for its role in facilitating cellular processes that involve copper-dependent enzymatic activity. It is derived from the native peptide GHK, which naturally occurs in human blood plasma. The addition of copper enhances its interaction with specific cellular receptors, potentially influencing processes such as angiogenesis, tissue regeneration, and cellular uptake mechanisms. Researchers utilize GHK-Cu in studies focused on its mechanisms of action, toxicity profiles, and efficacy in controlled experimental settings.

Research Overview

GHK-Cu has been extensively investigated in studies involving skin wound healing, cellular repair mechanisms, and its potential as a bioavailable copper source. In preclinical research, it has demonstrated efficacy in accelerating tissue regeneration in animal models, often through mechanisms that involve enhanced collagen deposition, improved vascularization, and reduced inflammation. Due to its low toxicity profile in laboratory settings, GHK-Cu is frequently utilized as a reference compound in studies examining peptide biology, metal-peptide interactions, and biomedical applications.

Key Research Focus Areas

• Wound Healing: GHK-Cu has been evaluated in studies investigating its role in promoting epidermal and dermal regeneration, often in models of acute or chronic wounds.
• Cellular Uptake and Signaling: Research has explored how GHK-Cu interacts with cell membranes and intracellular pathways, particularly those involving copper transport proteins.
• Angiogenesis: Studies have examined its potential to enhance vascular formation, which is critical for tissue repair and regeneration.
• Toxicity and Safety: Preclinical investigations have assessed GHK-Cu’s safety profile in various biological systems, including its effects on non-target tissues and organ systems.
• Metal-Peptide Interactions: Research has analyzed the structural and functional implications of copper incorporation into peptides, particularly in relation to peptide stability and bioactivity.

Important Compliance and Safety Information

GHK-Cu is intended solely for research purposes and must be handled with the utmost care.
Users are responsible for ensuring compliance with all applicable local, regional, and national
laws and regulations governing peptide synthesis, storage, and distribution. Users must ensure
compliance with all relevant regulations governing research materials, including those related to
biohazards, chemical safety, and experimental oversight. Proper handling, storage, and disposal
procedures must be followed at all times. Research institutions conducting studies involving GHK-Cu
must adhere to Institutional Review Board (IRB) or equivalent
biosafety procedures, laboratory handling standards, and animal welfare protocols.

Due to its biological activity, GHK-Cu requires proper containment measures,
sterile handling techniques, and controlled storage procedures to minimize contamination
and unintended exposure. GHK-Cu is not intended for therapeutic or diagnostic applications
in humans or animals, and should only be utilized within a licensed research environment. Always consult
with a qualified researcher, laboratory supervisor, or academic institution before use. Responsibility for
proper experimental design, safety protocols, and documentation rests solely with the investigator.

For research use only. Not for human or animal consumption.

Recommended Storage Protocol – 100 mg

Recommended Reconstitution Protocol – 100 mg